CompletedPhase 2/3

Intranasal Ketamine as a Sedative for Venipuncture

39 participantsStarted 2015-04

Plain-language summary

Randomized clinical trial, controlled, double-blind, parallel two-arm.

Who can participate

Age range3 Months – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children hospitalized in the Pediatric Inpatient Units, with the presence of legal guardian; * Aged 3 months to 12 years; * Requiring venipuncture independent research. Exclusion Criteria: * Severe neurological sequelae; * Patients who need immediate venipuncture at risk; * Presence of active nosebleeds; * Patients using drugs sedative and analgesic continuos; * Children who have experienced clinical change with ketamine.

What they're measuring

Decreased venipuncture Time

Timeframe: Expected 3 minutes difference between the 2 groups

Trial details

NCT IDNCT02929524

SponsorHospital de Clinicas de Porto Alegre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-10

View on ClinicalTrials.gov More Respiratory Tract Disease trials